Zydus gets USFDA nod for schizophrenia treatment drug

The company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said in a BSE filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news